Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sotera Health ( (SHC) ) just unveiled an update.
On May 5, 2026, Sotera Health announced that its board appointed industry veteran Alton Shader as chief executive officer and Class II director effective May 26, 2026, while incumbent CEO and chairman Michael B. Petras, Jr. will shift to the role of executive chairman and remain on the board. Shader’s offer package includes a $1 million base salary, substantial equity-based incentives and severance protections, while Petras’ amended agreement sets his executive chairman salary at $900,000 with continued participation in bonus and long-term incentive programs, underscoring an orderly succession aimed at continuity of leadership and alignment with shareholders.
In a separate first-quarter 2026 update, Sotera reported net revenue growth of 10.0% year on year to start the period ended March 31, 2026, with net income swinging to a $27 million profit from a $13 million loss and adjusted EBITDA up 10.5%. Growth was led by Sterigenics and Nordion, which posted solid price- and volume-driven gains and margin expansion, while Nelson Labs softened modestly, and management reaffirmed its full-year 2026 guidance for mid-single-digit revenue and adjusted EBITDA growth, supported by a net leverage ratio of 3.2x, over $900 million of liquidity and an expanded, more independent board and public float of roughly 90%.
The most recent analyst rating on (SHC) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on Sotera Health stock, see the SHC Stock Forecast page.
Spark’s Take on SHC Stock
According to Spark, TipRanks’ AI Analyst, SHC is a Neutral.
The score is supported by improving fundamentals and a constructive 2026 outlook (growth, slight margin expansion, cash generation and leverage reduction). It is weighed down by a still debt-heavy balance sheet, high earnings multiple (P/E ~64), and bearish technicals with the stock trading below key moving averages despite oversold readings.
To see Spark’s full report on SHC stock, click here.
More about Sotera Health
Sotera Health, based in Cleveland, is a global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, operating through its Sterigenics, Nordion and Nelson Labs businesses. The company focuses on sterilization using ethylene oxide and cobalt-60, and supports medical device and pharmaceutical manufacturers with regulatory-driven quality and safety needs.
Average Trading Volume: 2,808,949
Technical Sentiment Signal: Buy
Current Market Cap: $4.39B
Find detailed analytics on SHC stock on TipRanks’ Stock Analysis page.